Cyr Financial Inc. Decreases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Cyr Financial Inc. decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 69.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 644 shares of the biotechnology company's stock after selling 1,456 shares during the period. Cyr Financial Inc.'s holdings in Axon Enterprise were worth $383,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Public Sector Pension Investment Board increased its position in shares of Axon Enterprise by 19.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc raised its stake in Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock valued at $4,227,000 after buying an additional 895 shares in the last quarter. Foundations Investment Advisors LLC purchased a new stake in Axon Enterprise during the 3rd quarter worth about $221,000. Sequoia Financial Advisors LLC boosted its position in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company's stock worth $690,000 after acquiring an additional 81 shares in the last quarter. Finally, Axxcess Wealth Management LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at about $814,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on AXON. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday. JMP Securities upped their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research note on Thursday, October 31st. Finally, Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research report on Monday, November 11th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of "Moderate Buy" and an average price target of $524.85.

Axon Enterprise Trading Up 2.1 %

Shares of Axon Enterprise stock opened at $653.43 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $49.82 billion, a price-to-earnings ratio of 168.85, a price-to-earnings-growth ratio of 6.41 and a beta of 1.04. Axon Enterprise, Inc. has a 52-week low of $247.04 and a 52-week high of $698.67. The company's 50-day simple moving average is $619.32 and its 200-day simple moving average is $479.00.

Insider Transactions at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the firm's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company's stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 50,545 shares of company stock valued at $30,721,337. Corporate insiders own 6.10% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.